:max_bytes(150000):strip_icc()/GettyImages-2212439348-b2d7da6d31bf4a99814789307b69ae51.jpg)
Berkshire Hathaway's Q2 regulatory filing revealed significant portfolio adjustments, including an increased holding of 5 million shares in UnitedHealth Group (UNH), valued at approximately $1.6 billion, which led to a 10% surge in UNH shares following a prior 46% decline. The conglomerate also established new positions in D.R. Horton, Lamar Advertising, and Nucor, while exiting T-Mobile US and trimming stakes in Apple and Bank of America. These strategic moves are generating a "Buffett Bounce" for the favored stocks and offer insight into Berkshire's current investment focus.
Berkshire Hathaway's Q2 regulatory filing reveals a significant, high-conviction investment in UnitedHealth Group (UNH), with its holding increasing to 5 million shares valued at approximately $1.6 billion. This move is particularly noteworthy given Berkshire began accumulating the position in Q4 under a confidentiality request, suggesting a strategic decision to buy into a company whose shares had fallen 46% and hit a post-pandemic low prior to the announcement. The market's reaction was a 10% surge in UNH stock, a classic "Buffett Bounce" that underscores the weight of Berkshire's endorsement. The filing also signaled a broader strategic allocation, with new positions initiated in homebuilder D.R. Horton (DHI), Lamar Advertising (LAMR), and steelmaker Nucor (NUE), indicating a bullish view on specific cyclical sectors. Concurrently, Berkshire divested its entire stake in T-Mobile US (TMUS) and trimmed its large, long-standing positions in Apple (AAPL) and Bank of America (BAC), suggesting a rebalancing of capital towards newly identified opportunities.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.60
Ticker Sentiment